WallStreetZenWallStreetZen

NASDAQ: JAZZ
Jazz Pharmaceuticals PLC Stock Ownership - Who owns Jazz Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Jazz Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mark Douglas SmithDirector2026-06-151,157$230.55
$266.75kSell
Neena M. PatilEVP Chief Legal Officer2026-06-101,200$231.83
$278.20kSell
Bruce C. CozaddDirector2026-06-016,000$235.12
$1.41MSell
Seamus MulliganDirector2026-05-283,415$138.08
$471.54kBuy
Samantha PearceEVP Chief Commercial Officer2026-05-286,907$235.41
$1.63MSell
Samantha PearceEVP Chief Commercial Officer2026-05-286,907$109.45
$755.97kBuy
Neena M. PatilEVP Chief Legal Officer2026-05-281,192$236.97
$282.47kSell
Heather Ann McSharryDirector2026-05-222,000$241.00
$482.00kSell
Rick E. WinninghamDirector2026-05-222,741$241.57
$662.14kSell
Rick E. WinninghamDirector2026-05-223,415$138.08
$471.54kBuy

1 of 10

JAZZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JAZZ insiders and whales buy or sell their stock.

JAZZ Shareholders

What type of owners hold Jazz Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP48.74%30,583,176$6.87BInsider
Kkr Jp III LLC32.00%20,078,838$4.51BInsider
Michael W. Michelson29.60%18,571,250$4.17BInsider
Kkr Jp LLC29.58%18,557,365$4.17BInsider
Paul E. Raether29.58%18,557,365$4.17BInsider
Kkr Group Holdings LP15.85%9,942,946$2.23BInsider
William J. Janetschek13.67%8,577,974$1.93BInsider
Kenneth W. Okeefe10.31%6,469,439$1.45BInsider
Bryan C. Cressey9.39%5,894,549$1.32BInsider
Blackrock Inc8.91%5,591,700$1.26BInstitution

1 of 3

JAZZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JAZZ29.89%70.11%Net SellingNet Selling
ASND99.19%0.81%Net SellingNet Selling
EXEL94.86%5.14%Net SellingNet Selling
BBIO64.71%35.29%Net SellingNet Selling
AXSM62.19%37.81%Net SellingNet Selling
View Top Biotech Stocks

Jazz Pharmaceuticals Stock Ownership FAQ

Who owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals (NASDAQ: JAZZ) is owned by 103.64% institutional shareholders, 243.13% Jazz Pharmaceuticals insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Jazz Pharmaceuticals shareholder, owning 30.58M shares representing 48.74% of the company. Kkr Group Partnership LP's Jazz Pharmaceuticals shares are currently valued at $6.87B.

If you're new to stock investing, here's how to buy Jazz Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.